Scope Law advises Crearene AG, Frauenfeld, Switzerland on further equity financing.
Crearene, an innovative medical technology company focused on improving the quality of life of dialysis patients by supplementing dialysis fluid with creatine, has successfully completed a further financing round with existing investors.
Comments